Strata Skin Sciences (SSKN)
(Delayed Data from NSDQ)
$0.94 USD
-0.01 (-0.73%)
Updated Mar 22, 2023 01:59 PM ET
2-Buy of 5 2
B Value F Growth C Momentum D VGM
Income Statements
Fiscal Year end for Strata Skin Sciences, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 | |
---|---|---|---|---|---|
Sales | NA | 30 | 23 | 32 | 30 |
Cost Of Goods | NA | 10 | 9 | 11 | 13 |
Gross Profit | NA | 20 | 14 | 20 | 17 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 24 | 18 | 23 | 20 |
Income After Depreciation & Amortization | 0 | -4 | -4 | -3 | -3 |
Non-Operating Income | NA | 2 | 0 | 0 | 0 |
Interest Expense | NA | 0 | 0 | 1 | 1 |
Pretax Income | NA | -3 | -4 | -4 | -4 |
Income Taxes | NA | 0 | 0 | 0 | 0 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -3 | -4 | -4 | -4 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | -3 | -4 | -4 | -4 |
Depreciation Footnote | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 0 | 0 | 2 | 2 |
Depreciation & Amortization (Cash Flow) | NA | 4 | 4 | 5 | 6 |
Income After Depreciation & Amortization | 0 | -4 | -4 | -3 | -3 |
Earnings Per Share Data | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 |
---|---|---|---|---|---|
Average Shares | NA | 34.05 | 33.61 | 34.46 | NA |
Diluted EPS Before Non-Recurring Items | NA | -0.14 | -0.13 | -0.11 | NA |
Diluted Net EPS (GAAP) | NA | -0.08 | -0.13 | -0.11 | -0.15 |
Fiscal Year end for Strata Skin Sciences, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/22 | 9/30/22 | 6/30/22 | 3/31/22 | 12/31/21 | |
---|---|---|---|---|---|
Sales | NA | 9.41 | 9.11 | 7.04 | 9.06 |
Cost Of Goods | NA | 3.61 | 4.11 | 2.91 | 3.06 |
Gross Profit | NA | 5.80 | 4.99 | 4.13 | 6.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 6.59 | 6.69 | 6.43 | 6.63 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -0.79 | -1.70 | -2.30 | -0.63 |
Non-Operating Income | NA | 0.04 | 0.01 | 0.00 | 0.04 |
Interest Expense | NA | 0.24 | 0.21 | 0.20 | 0.24 |
Pretax Income | NA | -1.00 | -1.89 | -2.50 | -0.83 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.02 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -1.00 | -1.89 | -2.50 | -0.85 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -1.00 | -1.89 | -2.50 | -0.85 |
Earnings Per Share Data | 12/31/22 | 9/30/22 | 6/30/22 | 3/31/22 | 12/31/21 |
---|---|---|---|---|---|
Average Shares | NA | 34.72 | 34.72 | 34.68 | 40.00 |
Diluted EPS Before Non-Recurring Items | NA | -0.03 | -0.05 | -0.07 | -0.02 |
Diluted Net EPS (GAAP) | NA | -0.03 | -0.05 | -0.07 | -0.02 |